Biopsy Incisional With Trepan in Periocular Lesions
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
The purpose of this study was to identify accuracy rates of 2mm punch biopsy technique in diagnosing periocular malignancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2008
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
March 18, 2009
CompletedFirst Posted
Study publicly available on registry
March 19, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedMarch 19, 2009
March 1, 2009
10 months
March 18, 2009
March 18, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
accuracy, positive predictive value, negative predictive value, sensitivity, specificity
In each case, the histology obtained at biopsy was compared with that identified at the time of tumor excision.
Study Arms (1)
Punch Biopsy
EXPERIMENTALInterventions
1. Instillation of anesthetic eye drops. 2. Asepsis 3. Placement of surgical cloths and drapes 4. Infiltration of the involved region with anesthetic solution plus adrenalin in1:200.00 dilution. 5. Trephination of the most typical area of the lesion with a punch (2mm in diameter) of stainless steel by applying gentle pressure and twisting the trephine until its introduction into the suspicious lesions 6. Removal of the excised tissue with the aid of an insulin needle or conjuntival forceps, the base then bein cut with an number 11 surgical blade
Eligibility Criteria
You may qualify if:
- All lesions were initially examined at the slitlamp, after which lesions with malignant characteristics such as texture, size or color alterations asociated with ulceration, prominent borders or elevated contours, irregular borders, telangiectasias or loss of eyelashes were included.
You may not qualify if:
- Lesions with not malignant characteristics
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rachel C Carneiro
University of Sao Paulo - Hospital das Clinicas
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 18, 2009
First Posted
March 19, 2009
Study Start
December 1, 2008
Primary Completion
October 1, 2009
Study Completion
December 1, 2009
Last Updated
March 19, 2009
Record last verified: 2009-03